These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25615422)

  • 21. Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine.
    Li H; Zhou W; Li L; Wu J; Liu X; Zhao L; Jia L; Sun Y
    Neoplasia; 2017 Jun; 19(6):509-518. PubMed ID: 28535453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.
    Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L
    Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
    Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
    EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of a neddylation blockade on HTLV-1-infected T cells
    Ishikawa C; Mori N
    Leuk Lymphoma; 2024 Jul; 65(7):978-988. PubMed ID: 38489672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.
    Zhang W; Liang Y; Li L; Wang X; Yan Z; Dong C; Zeng MS; Zhong Q; Liu XK; Yu J; Sun S; Liu X; Kang J; Zhao H; Jeong LS; Zhang Y; Jia L
    Cell Prolif; 2019 Mar; 52(2):e12536. PubMed ID: 30341788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma.
    Zhang Y; Shi CC; Zhang HP; Li GQ; Li SS
    Oncotarget; 2016 Jul; 7(29):45263-45274. PubMed ID: 27223074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AKT inhibitor MK-2206 sensitizes breast cancer cells to MLN4924, a first-in-class NEDD8-activating enzyme (NAE) inhibitor.
    Chen X; Cui D; Bi Y; Shu J; Xiong X; Zhao Y
    Cell Cycle; 2018; 17(16):2069-2079. PubMed ID: 30198810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.
    Luo Z; Yu G; Lee HW; Li L; Wang L; Yang D; Pan Y; Ding C; Qian J; Wu L; Chu Y; Yi J; Wang X; Sun Y; Jeong LS; Liu J; Jia L
    Cancer Res; 2012 Jul; 72(13):3360-71. PubMed ID: 22562464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program.
    Smith MA; Maris JM; Gorlick R; Kolb EA; Lock R; Carol H; Keir ST; Reynolds CP; Kang MH; Morton CL; Wu J; Smith PG; Yu J; Houghton PJ
    Pediatr Blood Cancer; 2012 Aug; 59(2):246-53. PubMed ID: 22012946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRFAP1 plays a protective role in neddylation inhibitor MLN4924-mediated gastric cancer cell death.
    Hu L; Bai ZG; Ma XM; Bai N; Zhang ZT
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8273-8280. PubMed ID: 30556867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2, and chromatin dynamics pathways.
    Garcia K; Blank JL; Bouck DC; Liu XJ; Sappal DS; Hather G; Cosmopoulos K; Thomas MP; Kuranda M; Pickard MD; Liu R; Bandi S; Smith PG; Lightcap ES
    Mol Cancer Ther; 2014 Jun; 13(6):1625-35. PubMed ID: 24672057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cells.
    Xu GW; Toth JI; da Silva SR; Paiva SL; Lukkarila JL; Hurren R; Maclean N; Sukhai MA; Bhattacharjee RN; Goard CA; Medeiros B; Gunning PT; Dhe-Paganon S; Petroski MD; Schimmer AD
    PLoS One; 2014; 9(4):e93530. PubMed ID: 24691136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Neddylation Inhibition on Inflammation-Induced MMP9 Gene Expression in Esophageal Squamous Cell Carcinoma.
    Hryniewicz-Jankowska A; Wierzbicki J; Tabola R; Stach K; Sossey-Alaoui K; Augoff K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NEDD8-activating enzyme inhibitor, MLN4924 (Pevonedistat) induces NOXA-dependent apoptosis through up-regulation of ATF-4.
    Liu X; Jiang Y; Wu J; Zhang W; Liang Y; Jia L; Yu J; Jeong LS; Li L
    Biochem Biophys Res Commun; 2017 Jun; 488(1):1-5. PubMed ID: 28450112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme.
    Yang D; Tan M; Wang G; Sun Y
    PLoS One; 2012; 7(3):e34079. PubMed ID: 22457814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neddylation inhibition activates the protective autophagy through NF-κB-catalase-ATF3 Axis in human esophageal cancer cells.
    Liang Y; Jiang Y; Jin X; Chen P; Heng Y; Cai L; Zhang W; Li L; Jia L
    Cell Commun Signal; 2020 May; 18(1):72. PubMed ID: 32398095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor.
    Wei D; Li H; Yu J; Sebolt JT; Zhao L; Lawrence TS; Smith PG; Morgan MA; Sun Y
    Cancer Res; 2012 Jan; 72(1):282-93. PubMed ID: 22072567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting neddylation inhibits intravascular survival and extravasation of cancer cells to prevent lung-cancer metastasis.
    Jiang Y; Liang Y; Li L; Zhou L; Cheng W; Yang X; Yang X; Qi H; Yu J; Jeong LS; Hoffman RM; Zheng P; Jia L
    Cell Biol Toxicol; 2019 Jun; 35(3):233-245. PubMed ID: 31140025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR.
    Zhou L; Chen S; Zhang Y; Kmieciak M; Leng Y; Li L; Lin H; Rizzo KA; Dumur CI; Ferreira-Gonzalez A; Rahmani M; Povirk L; Chalasani S; Berger AJ; Dai Y; Grant S
    Blood; 2016 May; 127(18):2219-30. PubMed ID: 26851293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MLN4924 inhibits cell proliferation by targeting the activated neddylation pathway in endometrial carcinoma.
    Liu H; Bei Q; Luo X
    J Int Med Res; 2021 Jun; 49(6):3000605211018592. PubMed ID: 34082605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.